Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023

Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ:PCRX) will report its second quarter financial results on August 2, 2023. A live conference call and webcast will be held at 8:30 a.m. ET. Interested parties can participate in the Q&A session via telephone by pre-registering. A replay of the webcast will be available on the Pacira website for two weeks.

TAMPA, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on Wednesday, August 2, 2023. Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.

For listeners who wish to participate in the question and answer session via telephone, please pre-register here. All registrants will receive dial-in information and a PIN allowing them to access the live call. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com. For those unable to participate in the live call, a replay of the webcast will be available on the Pacira website for approximately two weeks following the call.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL^® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA^® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº^®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When will Pacira BioSciences report its second quarter financial results?

Pacira BioSciences will report its second quarter financial results on August 2, 2023.

What time will the live conference call and webcast be held?

The live conference call and webcast will be held at 8:30 a.m. ET.

How can I participate in the question and answer session?

Listeners can participate in the question and answer session via telephone by pre-registering.

Where can I access the live audio of the conference call?

Interested parties can access the live audio of the conference call on the Pacira website at investor.pacira.com.

How long will the replay of the webcast be available?

The replay of the webcast will be available on the Pacira website for approximately two weeks following the call.